|
|
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data
Sébastien Bailly
,
Olivier Leroy
,
Philippe Montravers
,
Jean-Michel Constantin
,
Hervé Dupont
et al.
Journal articles
hal-01205360v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Suspicion de péritonite à Candida dans l’étude AMARCAND II : peut-on prédire les patients qui vont avoir une culture positive ?
Hervé Dupont
,
Philippe Montravers
,
Jean-Pierre Gangneux
,
Élie Azoulay
,
Jean-Michel Constantin
et al.
Journal articles
hal-01244999v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure The EMPIRICUS Randomized Clinical Trial
Kada Klouche
,
Samir Jaber
,
Jean-Louis Trouillet
,
Fabrice Bruneel
,
Laurent Argaud
et al.
Journal articles
hal-01405822v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study
Élie Azoulay
,
Pedro Castro
,
Adel Maamar
,
Victoria Metaxa
,
Alice Gallo de Moraes
et al.
Journal articles
hal-03208127v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
Olivier Leroy
,
Sébastien Bailly
,
Jean-Pierre Gangneux
,
Jean-Paul Mira
,
Patrick Devos
et al.
Journal articles
hal-01259216v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|